Loading...
MHC II Lung Cancer Vaccines Prime and Boost Tumor-specific CD4(+) T Cells that Cross-React with Multiple Histologic Subtypes of Non-small Cell Lung Cancer Cells
Non-small cell lung cancer (NSCLC) is the major cause of lung cancer-related deaths in the United States. We are developing cell-based vaccines as a new approach for the treatment of NSCLC. NSCLC is broadly divided into three histologic subtypes: adenocarcinoma, squamous cell carcinoma, and large ce...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2947152/ https://ncbi.nlm.nih.gov/pubmed/20473949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.25462 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|